• Profile
Close

Impact of rapid transition to telemedicine-based delivery on allergy/immunology care during COVID-19

The Journal of Allergy and Clinical Immunology: In Practice Apr 26, 2021

Tsao LR, Villanueva SA, Pines DA, et al. - Researchers report the results of rapid transition to telemedicine (TM)-based care (video visit followed by in-person visits dedicated to diagnostic and therapeutic procedures when required) at an academic allergy/immunology (A/I) practice during COVID-19. Of patients originally scheduled between 3/10/20-4/30/20, overall 69% (265/382) were able to complete video visits. Significant reductions in environmental and food skin testing completion rates were noted with TM-based care vs in-person care. Overall, continued A/I care delivery was permitted by transitioning to TM-based care, strategies are still required to attain higher testing completion rates as well as to make sure that video visits do not exacerbate existing disparities.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay